ixX pharma: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ixX pharma
Largest movements
- Financial fixed assets +€1.7m
up €1.7m (+108626.2%), from €1,565 to €1.7m
of which Affiliated companies: +€1.7m
- Tangible fixed assets -€626,712
down €626,712 (-85.8%), from €730,482 to €103,770
of which Land and buildings: -€514,714
- Stocks and contracts -€304,525
down €304,525 (-12.6%), from €2.4m to €2.1m
- Receivables within one year +€177,909
up €177,909 (+3.1%), from €5.8m to €6.0m
of which Other amounts receivable: +€2.0m
- Other debts +€1.3m
new in 2025: €1.3m
- Trade debts -€1.2m
down €1.2m (-51.3%), from €2.3m to €1.1m
- Profit (loss) carried forward +€642,646
up €642,646 (+26.7%), from €2.4m to €3.0m
- Tax, wage and social debts +€246,009
up €246,009 (+32.7%), from €751,898 to €997,907
of which Taxes: +€231,237
- Turnover -€1.1m
down €1.1m (-8.9%), from €12.8m to €11.6m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,293,927 | €11,274,036 | +€980,109 | +9.5% |
| Fixed assets | 21/28 | €732,047 | €1,810,060 | +€1.1m | +147.3% |
| Intangible fixed assets | 21 | - | €4,725 | +€4,725 | |
| Tangible fixed assets | 22/27 | €730,482 | €103,770 | -€626,712 | -85.8% |
| Land and buildings | 22 | €514,714 | - | -€514,714 | |
| Plant, machinery and equipment | 23 | €127,478 | €10,530 | -€116,948 | -91.7% |
| Furniture and vehicles | 24 | €6,390 | - | -€6,390 | |
| Assets under construction and advance payments | 27 | €81,900 | €93,240 | +€11,340 | +13.8% |
| Financial fixed assets | 28 | €1,565 | €1,701,565 | +€1.7m | +108626.2% |
| Affiliated companies | 280/1 | - | €1,700,000 | +€1.7m | |
| Participating interests | 280 | - | €1,700,000 | +€1.7m | |
| Other financial fixed assets | 284/8 | €1,565 | €1,565 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €1,565 | €1,565 | = | 0.0% |
| Current assets | 29/58 | €9,561,880 | €9,463,976 | -€97,904 | -1.0% |
| Stocks and contracts in progress | 3 | €2,408,981 | €2,104,456 | -€304,525 | -12.6% |
| Stocks | 30/36 | €2,408,981 | €2,104,456 | -€304,525 | -12.6% |
| Goods purchased for resale | 34 | €2,408,981 | €2,104,456 | -€304,525 | -12.6% |
| Amounts receivable within one year | 40/41 | €5,811,539 | €5,989,448 | +€177,909 | +3.1% |
| Trade receivables | 40 | €2,963,214 | €1,170,233 | -€1.8m | -60.5% |
| Other amounts receivable | 41 | €2,848,325 | €4,819,215 | +€2.0m | +69.2% |
| Cash at bank and in hand | 54/58 | €1,313,062 | €1,347,465 | +€34,403 | +2.6% |
| Deferred charges and accrued income | 490/1 | €28,298 | €22,607 | -€5,691 | -20.1% |
| Total equity and liabilities | 10/49 | €10,293,927 | €11,274,036 | +€980,109 | +9.5% |
| Equity | 10/15 | €6,283,477 | €6,926,124 | +€642,646 | +10.2% |
| Contributions | 10/11 | €599,949 | €599,949 | = | 0.0% |
| Capital | 10 | €490,000 | €490,000 | = | 0.0% |
| Issued capital | 100 | €490,000 | €490,000 | = | 0.0% |
| Contributions outside capital | 11 | €109,949 | €109,949 | = | 0.0% |
| Share premium | 1100/10 | €109,949 | €109,949 | = | 0.0% |
| Reserves | 13 | €3,278,048 | €3,278,048 | = | 0.0% |
| Non-distributable reserves | 130/1 | €49,600 | €49,600 | = | 0.0% |
| Legal reserve | 130 | €49,600 | €49,600 | = | 0.0% |
| Distributable reserves | 133 | €3,228,448 | €3,228,448 | = | 0.0% |
| Profit (loss) carried forward | 14 | €2,405,481 | €3,048,127 | +€642,646 | +26.7% |
| Amounts payable | 17/49 | €4,010,450 | €4,347,912 | +€337,462 | +8.4% |
| Amounts payable within one year | 42/48 | €4,010,450 | €4,347,912 | +€337,462 | +8.4% |
| Financial debts | 43 | €1,000,000 | €1,000,000 | = | 0.0% |
| Credit institutions | 430/8 | €1,000,000 | €1,000,000 | = | 0.0% |
| Trade debts | 44 | €2,258,553 | €1,100,006 | -€1.2m | -51.3% |
| Suppliers | 440/4 | €2,258,553 | €1,100,006 | -€1.2m | -51.3% |
| Taxes, remuneration and social security | 45 | €751,898 | €997,907 | +€246,009 | +32.7% |
| Taxes | 450/3 | €318,129 | €549,366 | +€231,237 | +72.7% |
| Remuneration and social security | 454/9 | €433,768 | €448,540 | +€14,772 | +3.4% |
| Other amounts payable | 47/48 | - | €1,250,000 | +€1.3m | |
| Operating income | 70/76A | €12,195,644 | €12,501,902 | +€306,258 | +2.5% |
| Turnover | 70 | €12,768,776 | €11,631,876 | -€1.1m | -8.9% |
| Change in stocks of work in progress, finished goods and contracts in progress | 71 | -€681,719 | - | +€681,719 | |
| Other operating income | 74 | €104,021 | €90,145 | -€13,876 | -13.3% |
| Non-recurring operating income | 76A | €4,566 | €779,882 | +€775,316 | +16979.8% |
| Operating charges | 60/66A | €10,374,350 | €10,304,742 | -€69,607 | -0.7% |
| Goods for resale, raw materials and consumables | 60 | €4,757,836 | €4,694,200 | -€63,636 | -1.3% |
| Purchases | 600/8 | €4,643,902 | €4,389,676 | -€254,226 | -5.5% |
| Change in stocks: decrease (increase) | 609 | €113,934 | €304,525 | +€190,591 | +167.3% |
| Services and other goods | 61 | €2,917,036 | €3,010,279 | +€93,243 | +3.2% |
| Remuneration, social security and pensions | 62 | €2,567,262 | €2,508,191 | -€59,071 | -2.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €119,277 | €82,740 | -€36,537 | -30.6% |
| Other operating charges | 640/8 | €12,939 | €9,333 | -€3,607 | -27.9% |
| Operating profit (loss) | 9901 | €1,821,295 | €2,197,160 | +€375,866 | +20.6% |
| Financial income | 75/76B | €87,401 | €108,484 | +€21,082 | +24.1% |
| Recurring financial income | 75 | €87,401 | €108,484 | +€21,082 | +24.1% |
| Income from current assets | 751 | €87,061 | €108,482 | +€21,422 | +24.6% |
| Other financial income | 752/9 | €340 | €1 | -€339 | -99.6% |
| Financial charges | 65/66B | €121,951 | €155,736 | +€33,784 | +27.7% |
| Recurring financial charges | 65 | €121,951 | €155,736 | +€33,784 | +27.7% |
| Debt charges | 650 | €118,182 | €153,663 | +€35,481 | +30.0% |
| Other financial charges | 652/9 | €3,769 | €2,072 | -€1,697 | -45.0% |
| Profit (loss) for the period before taxes | 9903 | €1,786,744 | €2,149,908 | +€363,164 | +20.3% |
| Income taxes | 67/77 | €580,120 | €457,262 | -€122,858 | -21.2% |
| Taxes | 670/3 | €580,120 | €537,477 | -€42,643 | -7.4% |
| Tax adjustments and reversals of tax provisions | 77 | - | €80,215 | +€80,215 | |
| Profit (loss) for the period | 9904 | €1,206,625 | €1,692,646 | +€486,022 | +40.3% |
| Transfer from tax-exempt reserves | 789 | €1,018,820 | - | -€1.0m | |
| Profit (loss) for the period to be appropriated | 9905 | €2,225,445 | €1,692,646 | -€532,798 | -23.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 12 October 2026 via checked.be.